feed

S&P 500—

NASDAQ—

DOW—

RUSSELL—

VIX—

US10Y—

DXY—

EUR/USD—

GBP/USD—

GOLD—

WTI—

BTC—

ETH—

AArphraTerminal

Arphra/Issuer/PODD

PODD

Insulet Corporation

HealthcareMedical - DevicesUSUSD

$144.94

-0.78%Live · FMPMay 29, 2026

Market cap

$10.04B

52w range

140.63 – 354.88

P / E

—

EPS

—

Volume

2.08M

Revenue · FY

$2.71B

+30.73% YoY

Explain this page

Arphra AIPlain-English read on Insulet Corporation’s valuation

Press releasestopic:all earnings guidance dividend buyback mna ipo split layoffs lawsuit regulation rating executive product macro

News sentiment · 90d

DB · scored

2026-05-04 bullish neutral bearish2026-05-13

Topic mix · 30d

DB · scored

earnings1.001
guidance1.001
ipo1.001
rating1.001

News

DB · scored7

Insulet Corporation (PODD) Presents at Bank of America Global Healthcare Conference 2026 Transcript
May 13, 2026Seeking Alpha
Here's Why Insulet (PODD) is a Strong Growth Stock+1.00
May 12, 2026Zacks Investment Research
Insulet Reports First Quarter 2026 Results+1.00
May 06, 2026Business Wireguidance ipo
Insulet (PODD) is an Incredible Growth Stock: 3 Reasons Why+1.00
May 04, 2026Zacks Investment Research
Insulet (PODD) Upgraded to Buy: Here's Why+1.00
May 04, 2026Zacks Investment Researchearnings rating
Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes
May 04, 2026Business Wire
Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes
May 04, 2026Business Wire